Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A to prevent post-traumatic elbow rigidity
2007-000919-29Phase 3Active
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in Muscle rigidity, sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: Passive and active motor recovery of the elbow. Started Sep 2007; status: active.
02
Drugs
botulinum toxin type A
03
Conditions
Muscle rigidity
Beyond the preview
Go deeper on 2007-000919-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000919-29.